You are here
Hong Kong seeks to cash in on frenzy for Chinese biotech stocks
CHINESE drug companies have been on a tear in the US stock market. Now, entrepreneurs and investors betting on the Asian country's fledgling biotechnology industry see another reason for optimism.
The stock exchange in Hong Kong - home to the world's fourth-largest equity
- CALL +65 6388 3838
- EMAIL email@example.com